Since August, 2005, this news digest has been a complimentary service of GBP Capital, a private equity firm investing in early to mid-stage life science companies. See www.gbpcap.com. The digest is published two to four days a week. If you have colleagues who would be interested in receiving this digest by email, they can be added to the list at: http://www.gbpcap.com/ <http://www.gbpcap.com/> . Also, the complete history of the entire content of all news articles in our digests since August, 2005 is searchable with Google's enterprise search engine at the same site.
Source - EurekAlert - Biology:
Public Release: 10-Dec-2009
Study reveals H1N1 unexpected weakness <http://www.eurekalert.org/pub_releases/2009-12/ru-srh121009.php>
The H1N1 influenza virus has been keeping a secret that may be the key to defeating it and other flu viruses as well. Researchers at Rice University and Baylor College of Medicine have found what they believe is a weakness in H1N1's method for evading detection by the immune system.
Contact: David Ruth
druth@rice.edu <mailto:druth@rice.edu>
713-348-6327
Rice University <http://media.rice.edu/>
Public Release: 10-Dec-2009
Potential new heart attack biomarker uncovered <http://www.eurekalert.org/pub_releases/2009-12/asfb-pnh121009.php>
In a study appearing in this month's Molecular and Cellular Proteomics, researchers have identified cardiac myosin-binding protein C as a potential new diagnostic biomarker for heart attacks, one that may be particularly valuable for mild attacks in which traditional diagnostic proteins may not be abundant enough.
Contact: Nick Zagorski
nzagorski@asbmb.org <mailto:nzagorski@asbmb.org>
301-634-7366
American Society for Biochemistry and Molecular Biology <http://www.asbmb.org/>
Public Release: 10-Dec-2009
Hebrew University, American researchers show 'trigger' to stem cell differentiation <http://www.eurekalert.org/pub_releases/2009-12/thuo-hua121009.php>
A gene which is essential for stem cells' capabilities to become any cell type has been identified by researchers at the Hebrew University of Jerusalem and the University of California, San Francisco.
Contact: Jerry Barach
jerryb@savion.huji.ac.il <mailto:jerryb@savion.huji.ac.il>
972-258-82904
The Hebrew University of Jerusalem <http://www.huji.ac.il/>
Public Release: 9-Dec-2009
Potential cancer drug may offer new hope for asthma patients <http://www.eurekalert.org/pub_releases/2009-12/uoe-pcd120909.php>
A drug being tested to treat cancer could also help patients suffering from asthma, research has suggested. Scientists at the University of Edinburgh found that the drug -- R-Roscovitine -- helps to kill certain immune cells which can exacerbate symptoms associated with asthma.
Contact: Tara Womersley
tara.womersley@ed.ac.uk <mailto:tara.womersley@ed.ac.uk>
44-131-650-9836
University of Edinburgh <http://www.ed.ac.uk/>
Public Release: 9-Dec-2009
Coaxing injured nerve fibers to regenerate by disabling 'brakes' in the system <http://www.eurekalert.org/pub_releases/2009-12/chb-cin120809.php>
Expanding on prior research, Children's Hospital Boston scientists provide further evidence that regeneration of nerve fibers after brain or spinal cord injury is limited by a lack of response to growth factors induced by the injury. They show in mice that axons can regenerate vigorously when responsiveness is restored genetically -- a finding that could lead to ways of helping people recover from brain or spinal cord injury.
Contact: Jamie Newton
james.newton@childrens.harvard.edu <mailto:james.newton@childrens.harvard.edu>
617-919-3110
Children's Hospital Boston <http://www.childrenshospital.org/newsroom>
Public Release: 9-Dec-2009
A new target for lymphoma therapy <http://www.eurekalert.org/pub_releases/2009-12/chb-ant120709.php>
Researchers at Children's Hospital Boston have discovered how an oncogene gets activated in mature B cells, suggesting a new target for therapy in B cell lymphomas. The study, embargoed until Wednesday, December 9, 1 PM ET, marks the first time researchers have understood how the over-activation of c-myc can lead to blood-related cancers.
Contact: Rob Graham
Rob.Graham@childrens.harvard.edu <mailto:Rob.Graham@childrens.harvard.edu>
617-919-3110
Children's Hospital Boston <http://www.childrenshospital.org/newsroom>
Public Release: 9-Dec-2009
Low-density lipoprotein receptor reduces damage in Alzheimer's brain <http://www.eurekalert.org/pub_releases/2009-12/cp-llr120409.php>
The low-density lipoprotein receptor has received a lot of attention because of its connection with coronary heart disease and atherosclerosis, but now it appears as if it may have a beneficial influence in degenerative brain diseases.
Contact: Cathleen Genova
cgenova@cell.com <mailto:cgenova@cell.com>
617-397-2802
Cell Press <http://www.cellpress.com/>
Public Release: 9-Dec-2009
A new mouse could help understand how some lung cancer cells evade drug treatment <http://www.eurekalert.org/pub_releases/2009-12/tcob-anm120209.php>
A new study published in Disease Models and Mechanisms describes the development of drug resistance in mice with lung cancer. The lung tumors in mice result from changes similar to those seen in human patients. Also like humans, these tumors initially respond to drug treatment but eventually become resistant to therapy. Studying lung cancer cells in this model should provide insight into the mechanisms that make lung cancer cells resistant to current treatment methods and uncover new therapeutic targets.
Contact: Kristy Kain
kristy.kain@vanderbilt.edu <mailto:kristy.kain@vanderbilt.edu>
The Company of Biologists <http://www.biologists.com/>
Public Release: 9-Dec-2009
Stem cell derived neurons for research relevant to Alzheimer's and Niemann-Pick type C diseases <http://www.eurekalert.org/pub_releases/2009-12/asfc-scd112609.php>
Stem cell derived neurons may allow scientists to determine whether breakdowns in the transport of proteins, lipids and other materials within cells trigger the neuronal death and neurodegeneration that characterize Alzheimer's disease and the rarer but always fatal neurological disorder, Niemann-Pick Type C, according to a presentation that Lawrence B. Goldstein, Ph.D., will give at the American Society for Cell Biology annual meeting.
Contact: Cathy Yarbrough
sciencematter@yahoo.com <mailto:sciencematter@yahoo.com>
858-243-1814
American Society for Cell Biology <http://www.ascb.org/>
Public Release: 8-Dec-2009
Supportive materials will help regenerate heart tissue <http://www.jacobsschool.ucsd.edu/news/news_releases/release.sfe?id=907>
Bioengineers from University of California, San Diego, are developing new regenerative therapies for heart disease. The work could influence the way in which regenerative therapies for cardiovascular and other diseases are treated in the future.
Contact: Daniel Kane
dbkane@ucsd.edu <mailto:dbkane@ucsd.edu>
858-534-3262
University of California - San Diego <http://www.ucsd.edu/>
Public Release: 8-Dec-2009
Small addition to cancer drug may make big difference <http://www.eurekalert.org/pub_releases/2009-12/uof-sat120809.php>
The addition of a small molecule to the cancer drug Temozolomide disrupts repair mechanisms in a type of tumor cells that is highly resistant to treatment.
Contact: John Pastor
jdpastor@ufl.edu <mailto:jdpastor@ufl.edu>
352-273-5815
University of Florida <http://www.ufl.edu/>
Public Release: 7-Dec-2009
Researchers demonstrate nanoscale X-ray imaging of bacterial cells <http://www.eurekalert.org/pub_releases/2009-12/tum-rdn120709.php>
An ultra-high-resolution imaging technique using X-ray diffraction is a step closer to fulfilling its promise as a window on nanometer-scale structures in biological samples. In PNAS this week, researchers report progress in applying an approach to "lensless" X-ray microscopy that they introduced one year ago, with the potential to yield insights for evolutionary biology and biotechnology. They have produced the first images, using this technique, of biological cells -- specifically the intriguing polyextremophile Deinococcus radiourans.
Contact: Andreas Battenberg
battenberg@zv.tum.de <mailto:battenberg@zv.tum.de>
49-892-891-2890
Technische Universitaet Muenchen <http://www.tum.de/>
Public Release: 7-Dec-2009
Delivering medicine directly into a tumor <http://www.burnham.org/default.asp?contentID=853>
Researchers at Burnham Institute for Medical Research at University of California, Santa Barbara, have identified a peptide (a chain of amino acids) that specifically recognizes and penetrates cancerous tumors but not normal tissues. The peptide was also shown to deliver diagnostic particles and medicines into the tumor.
Contact: Josh Baxt
jbaxt@burnham.org <mailto:jbaxt@burnham.org>
858-795-5236
Burnham Institute <http://www.burnham-inst.org/>
Public Release: 7-Dec-2009
New computer model could lead to safer stents <http://www.eurekalert.org/pub_releases/2009-12/plos-ncm120709.php>
A study by HST scientists shows that the location of arterial stents is critical to efficient and safe drug delivery.
Contact: Vijaya B. Kolachalama
vbk@MIT.EDU <mailto:vbk@MIT.EDU>
Public Library of Science <http://www.plos.org/>
Public Release: 7-Dec-2009
UCLA researchers demonstrate that stem cells can be engineered to kill HIV <http://newsroom.ucla.edu/portal/ucla/ucla-researchers-demonstrate-that-149694.aspx>
Researchers from the UCLA AIDS Institute and colleagues have for the first time demonstrated that human blood stem cells can be engineered into cells that can target and kill HIV-infected cells -- a process that potentially could be used against a range of chronic viral diseases. The study provides proof-of-principle -- that is, a demonstration of feasibility -- that human stem cells can be engineered into the equivalent of a genetic vaccine.
Contact: Enrique Rivero
erivero@mednet.ucla.edu <mailto:erivero@mednet.ucla.edu>
310-794-2273
University of California - Los Angeles <http://www.newsroom.ucla.edu/>
Source - Science Daily:
Please note: Due to the format restrictions of Science Daily articles, you must click on the URL (web address) below the article summary, rather than the article title.
First Evidence of Brain Rewiring in Children: Reading Remediation Positively Alters Brain Tissue <http://www.sciencedaily.com/releases/2009/12/091209121200.htm>
December 10, 2009 — Scientists have uncovered the first evidence that intensive instruction to improve reading skills in young children causes the brain to physically rewire itself, creating new white matter that ...
http://www.sciencedaily.com/releases/2009/12/091209121200.htm
New Skin Stem Cells Surprisingly Similar to Those Found in Embryos <http://www.sciencedaily.com/releases/2009/12/091209121202.htm>
December 10, 2009 — Scientists have discovered a new type of stem cell in the skin that acts surprisingly like certain stem cells found in embryos: both can generate fat, bone, cartilage and even nerve ...
http://www.sciencedaily.com/releases/2009/12/091209121202.htm
Bone Marrow Cells May Significantly Reduce Risk of Second Heart Attack <http://www.sciencedaily.com/releases/2009/12/091208162650.htm>
December 10, 2009 — After heart attack patients' arteries were cleared by reperfusion, progenitor cells, derived from the patients' own bone marrow, were infused into that artery. This reduced the risk of death or ...
http://www.sciencedaily.com/releases/2009/12/091208162650.htm
Human Umbilical Stem Cells Cleared Mice's Cloudy Eyes <http://www.sciencedaily.com/releases/2009/12/091208132239.htm>
December 9, 2009 — New research from the University of Cincinnati (UC) may help in the recovery of lost vision for patients with corneal ...
http://www.sciencedaily.com/releases/2009/12/091208132239.htm
Blood Cancers: New Research Demonstrates Advances in Optimizing Treatments and Quality of Life <http://www.sciencedaily.com/releases/2009/12/091207095945.htm>
December 9, 2009 — New research explores optimal induction therapies for managing multiple myeloma, the importance of advance care planning for improved quality of life, and a potential new first-line therapy for ...
http://www.sciencedaily.com/releases/2009/12/091207095945.htm <http://www.sciencedaily.com/releases/2009/12/091207095945.htm>
Advances in Diagnosing and Treating Leukemia and Myeloproliferative Disorders <http://www.sciencedaily.com/releases/2009/12/091207095943.htm>
December 9, 2009 — Leukemia and myeloproliferative disorders are serious and often deadly blood cancers. Recent research introduces potential new treatment options and improved diagnostic methods for patients suffering ...
http://www.sciencedaily.com/releases/2009/12/091207095943.htm
Fast Method for Preparing Flu Vaccine: Use Bioreactors Instead of Chicken Eggs <http://www.sciencedaily.com/releases/2009/12/091209193506.htm>
December 9, 2009 — A shortage of flu vaccines may soon become a problem of the past. Researchers have developed an alternative process for producing large quantities of safe and effective vaccines at twice to four ...
http://www.sciencedaily.com/releases/2009/12/091209193506.htm
Why Cancer Cells Just Won't Die: Researcher Identifies Protein Which Regulates Cell Suicide <http://www.sciencedaily.com/releases/2009/12/091209114158.htm>
December 9, 2009 — When cells experience DNA damage, they'll try to repair it. But if that fails, the damaged cells are supposed to self-destruct, a process called apoptosis. A cancer researcher has identified a ...
http://www.sciencedaily.com/releases/2009/12/091209114158.htm
HIV-Related Memory Loss Linked to Alzheimer's Protein <http://www.sciencedaily.com/releases/2009/12/091207164840.htm>
December 8, 2009 — More than half of HIV patients experience memory problems and other cognitive impairments as they age, and doctors know little about the underlying causes. New research suggests HIV-related cognitive ...
http://www.sciencedaily.com/releases/2009/12/091207164840.htm
Gene Therapy and Stem Cells Save Limb <http://www.sciencedaily.com/releases/2009/12/091208162654.htm>
December 8, 2009 — Blood vessel blockage, a common condition in old age or diabetes, leads to low blood flow and results in low oxygen, which can kill cells and tissues. Such blockages can require amputation resulting ...
http://www.sciencedaily.com/releases/2009/12/091208162654.htm
Tiny RNA Has Big Impact on Lung Cancer Tumors <http://www.sciencedaily.com/releases/2009/12/091207095516.htm>
December 8, 2009 — Researchers reversed the growth of lung tumors in mice using a naturally occurring tumor suppressor microRNA. The study reveals that a tiny bit of RNA may one day play a big role in cancer treatment, ...
http://www.sciencedaily.com/releases/2009/12/091207095516.htm
Strategies to Protect New Brain Cells Against Alzheimer's Disease <http://www.sciencedaily.com/releases/2009/12/091203132148.htm>
December 8, 2009 — Scientists have discovered that two main causes of AD amyloid-beta (A²) peptides and apolipoprotein E4 (apoE4) impair the growth of new neurons born in adult brains. What is more, they have ...
http://www.sciencedaily.com/releases/2009/12/091203132148.htm
Autologous Stem Cell Transplantation for Soft Tissue Sarcoma: Insufficient Research Into Therapy <http://www.sciencedaily.com/releases/2009/12/091208132542.htm>
December 8, 2009 — Due to a lack of suitable studies, it is unclear whether patients with soft tissue sarcoma can benefit from autologous haematopoietic stem cell transplantation. Owing to the current gaps in ...
http://www.sciencedaily.com/releases/2009/12/091208132542.htm
New Hope for Diagnosis and Treatment of Intractable Pediatric Brain Tumors <http://www.sciencedaily.com/releases/2009/12/091207123103.htm>
December 7, 2009 — Scientists have discovered oncogenes capable of driving growth of normal human brain stem cells in a highly malignant pediatric brain tumor. The research has significant implications for clinical ...
http://www.sciencedaily.com/releases/2009/12/091207123103.htm
Source - Health Day:
Health Highlights: Dec. 10 2009 <http://www.healthday.com/Article.asp?AID=633927>
- Label Error Prompts Recall of Alka-Seltzer Cold Capsules
- Childhood Germ Exposure Offers Life-Long Protection: Study
- Drug, Health Care Costs Increase for Americans 18 to 44
- Senators Reach Deal on Health Bill Roadblock
- Antipsychotic Drugs May Carry Weight Gain Warning: FDA
- WHO Urges Stronger Action Against Smoking
- FDA Lags on Recommended Drug Safety Changes: GAO
Positioning of genes could aid in detecting whether cells are cancerous, experts say
Beer Ingredient Eyed in Prostate Cancer Prevention <http://www.healthday.com/Article.asp?AID=633830>
But experiments in rats should not encourage guys to drink up, experts say
Clinical Trials Update: Dec. 10, 2009 <http://www.healthday.com/Article.asp?AID=633931>
- COPD (Chronic Obstructive Pulmonary Disease)
- Bipolar Depression
- Healthy Volunteers (Females Ages 18-40)
- Abdominal Pain
- Gout
- Alzheimer's Disease
- Cholesterol
- Depression
- Low Back Pain
- Metastatic Colorectal Cancer
- Treatment Resistant Depression
- Attention Deficit Hyperactivity Disorder (ADHD)
Source - Yahoo Biotech News:
Facet Biotech's Board of Directors Unanimously Rejects Biogen Idec's Revised, Unsolicited Tender Offer as Inadequate <http://us.rd.yahoo.com/finance/industry/news/mostpop/*http:/biz.yahoo.com/iw/091210/0567652.html?.v=1> - Marketwire - Thu 8:30 am ET
Oncothyreon announces initiation of Phase 3 trial of Stimuvax in Asian patients with NSCLC <http://us.rd.yahoo.com/finance/industry/news/mostpop/*http:/biz.yahoo.com/prnews/091210/to552.html?.v=9> - PR Newswire - Thu 8:00 am ET
Oncothyreon Inc. today announced that Merck KGaA of Darmstadt, Germany, has initiated a Phase 3 trial of Stimuvax� in Asian patients with advanced non-small cell lung cancer . The trial, named INSPIRE , is anticipated to enroll approximately 420 patients in China, Hong Kong, South Korea, Singapore and Taiwan.
Source - Google Health News:
Gene Therapy May Save Limbs for Diabetics <http://www.google.com/url?sa=X&q=http://asweetlife.org/a-sweet-life-staff/in-the-news/health-news/gene-therapy-may-save-limbs-for-diabetics/3382/&ct=ga&cd=JmwD-tPJkrs&usg=AFQjCNEbVXFPQuUrZq4-5DG2YZOgunIJfQ>
A Sweet Life (blog)
The scientists say that with the help of gene therapy and stem cells they can help reactivate the body's response to hypoxia and save limbs. ...
More Stem Cell and Gene Therapy Progress Roundup <http://www.google.com/url?sa=X&q=http://nextbigfuture.com/2009/12/more-stem-cell-and-gene-therapy.html&ct=ga&cd=JmwD-tPJkrs&usg=AFQjCNGlee8vH3wp9MAcimBsP2BDyqQgNA>
Next Big Future (blog)
These studies lay the foundation for further therapeutic development that involves restoring damaged or defective immune responses toward a variety of ..
Gene therapy for glaucoma could have potential <http://www.google.com/url?sa=X&q=http://www.osnsupersite.com/view.aspx%3Frid%3D51002&ct=ga&cd=f8sfGVqWZlg&usg=AFQjCNGlqjk3kl_tTCyBKeq4Jz74YYej-w>
Kang Zhang While genetic therapy may offer potential benefits to glaucoma risk assessment and tre.
OSN Supersite - http://www.osnsupersite.com/rss.aspx <http://www.osnsupersite.com/rss.aspx>
Swine flu could be epidemic in January <http://www.google.com/url?sa=X&q=http://sanfordherald.com/pages/full_story/push%3Farticle-Swine%2Bflu%2Bcould%2Bbe%2Bepidemic%2Bin%2BJanuary%2520%26id%3D5030672-Swine%2Bflu%2Bcould%2Bbe%2Bepidemic%2Bin%2BJanuary%26instance%3Dhomesecondleft&ct=ga&a>
Sanford Herald
While the fear of avian flu, or H5N1, may arise, it's unlikely that it will spread to the US, she added. “ H5N1 is still kind of isolated to poultry workers ...
Ongoing H1N1 Outbreak Cover-up in China <http://www.google.com/url?sa=X&q=http://www.theepochtimes.com/n2/content/view/26103/&ct=ga&cd=cZkeFrdpryM&usg=AFQjCNFg3tn6mpBD1KP0sDmcvHNR5OMYKw>
The Epoch Times
He said, “Inside China, H5N1 has been existing for some time, so if there is really a reassortment between H1N1 and H5N1, it will be a disaster. ...
Source - Medical News Today:
StemCells, Inc. Welcomes Approval Of First Embryonic Stem Cell Lines Under New NIH Guidelines <http://www.medicalnewstoday.com/articles/173585.php>
StemCells, Inc. (NASDAQ: STEM) announced that it welcomes the approval yesterday by the National Institutes of Health (NIH) of the first 13 human embryonic stem cell <http://www.medicalnewstoday.com/info/stem_cell/whatarestemcells.php> (hESC) lines for use in NIH-funded research under the NIH Guidelines for Human Stem Cell Research adopted in July 2009. The guidelines implement President Obama's executive order of March 9, 2009 permitting the federal government, through the NIH, to support and conduct responsible, scientifically worthy human stem cell research, including human embryonic stem cell research. Stem cell research holds the potential to advance the understanding of many diseases at a fundamental, cellular level, and may open new avenues for treatments or cures. The Company considers this action by the federal government as a critical first step for the advancement of the stem cell field and for the future practice of medicine. StemCells is focused on the development and commercialization of cell-based technologies, including technologies relating to embryonic stem cells, induced pluripotent stem (iPS) cells, and tissue-derived (adult) stem cells. In its cellular medicine product development programs, the Company is currently focused on developing tissue-derived (adult) stem cells as cell-based therapeutics. The Company's lead product candidate, HuCNS-SC® cells (purified human neural stem cells), is in clinical development for the treatment of two fatal neurodegenerative disorders that primarily affect young children.
http://www.medicalnewstoday.com/articles/173585.php <http://www.medicalnewstoday.com/articles/173585.php>
The International Myeloma Foundation Says Important Studies May Offer New Approaches To Treating Multiple Myeloma <http://www.medicalnewstoday.com/articles/173517.php>
The International Myeloma Foundation (IMF)-supporting research and providing education, advocacy and support for myeloma <http://www.medicalnewstoday.com/articles/161727.php> patients, families, researchers and physicians- says a large number of abstracts - nearly a quarter of the presentations submitted this year to the annual meeting of the American Society of Hematology (ASH) were for myeloma, with one being presented at the prestigious plenary session. Particularly interesting this year, were a group of studies that may represent important steps forward in the treatment or understanding of the disease from its earliest stages on. "This has been one of the most exciting medical meetings for myeloma in recent years," said Susie Novis, president and co-founder of the IMF. "We believe patients with myeloma and related blood cancers <http://www.medicalnewstoday.com/info/cancer-oncology/whatiscancer.php> will have more treatment options that could lead to a better quality of life."
http://www.medicalnewstoday.com/articles/173517.php <http://www.medicalnewstoday.com/articles/173517.php>
New Platinum Compound Potentially More Effective At Destroying Cancer Tumors <http://www.medicalnewstoday.com/articles/173352.php>
Researchers in the US have developed and tested a new platinum compound that appears to be more effective at destroying cancer <http://www.medicalnewstoday.com/info/cancer-oncology/whatiscancer.php> tumors than cisplatin, a commonly used FDA-approved drug that is administered by itself or with other drugs to treat mostly advanced bladder, ovarian, testicular and other cancers. The study is to be published in this week's issue of the Proceedings of the National Academy of Sciences, and is the work of chemists from the Massachusetts Institute of Technology (MIT).
http://www.medicalnewstoday.com/articles/173352.php <http://www.medicalnewstoday.com/articles/173352.php>
Vitamin D Levels Associated With Survival In Lymphoma Patients Discovered By Mayo Clinic And Collaborators <http://www.medicalnewstoday.com/articles/173142.php>
A new study has found that the amount of vitamin D <http://www.medicalnewstoday.com/articles/161618.php> in patients being treated for diffuse large B-cell lymphoma <http://www.medicalnewstoday.com/articles/146136.php> was strongly associated with cancer <http://www.medicalnewstoday.com/info/cancer-oncology/whatiscancer.php> progression and overall survival. The results were presented at the annual meeting of the American Society of Hematology <http://www.hematology.org/> in New Orleans. "These are some of the strongest findings yet between vitamin D and cancer outcome," says the study's lead investigator, Matthew Drake, M.D., Ph.D. <http://www.mayoclinic.org/bio/13726218.html> , an endocrinologist at Mayo Clinic in Rochester. "While these findings are very provocative, they are preliminary and need to be validated in other studies. However, they raise the issue of whether vitamin D supplementation might aid in treatment for this malignancy, and thus should stimulate much more research."
http://www.medicalnewstoday.com/articles/173142.php <http://www.medicalnewstoday.com/articles/173142.php>
S ource - MIT 's Technology Review:
Brain Implant Cuts Seizures <http://www.technologyreview.com/biomedicine/24095/>
http://www.technologyreview.com/biomedicine/24095/
Breakthrough Flu Drug Might Already Exist <http://www.technologyreview.com/biomedicine/24084/>
http://www.technologyreview.com/biomedicine/24084/
New Endoscope Sees What Lies Beneath <http://www.technologyreview.com/biomedicine/24052/>
http://www.technologyreview.com/biomedicine/24052/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.